Estrella Financial Statements From 2010 to 2026

ESLA Stock   1.20  0.22  15.49%   
Estrella Immunopharma's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Estrella Immunopharma's valuation are provided below:
Market Capitalization
81.5 M
Earnings Share
(0.24)
We have found eighty-seven available fundamental signals for Estrella Immunopharma, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to verify all of Estrella Immunopharma prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road.
Check Estrella Immunopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Estrella Immunopharma's main balance sheet or income statement drivers, such as Tax Provision of 2 K, Selling General Administrative of 1.2 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 289. Estrella financial statements analysis is a perfect complement when working with Estrella Immunopharma Valuation or Volatility modules.
  
Build AI portfolio with Estrella Stock
Check out the analysis of Estrella Immunopharma Correlation against competitors.
For information on how to trade Estrella Stock refer to our How to Trade Estrella Stock guide.

Estrella Immunopharma Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding26.4 M42.2 M31.8 M
Pretty Stable
Other Liabilities11 K11.5 K14 K
Slightly volatile
Cash And Short Term Investments1.3 M825.2 K3.1 M
Slightly volatile
Liabilities And Stockholders Equity4.8 M2.8 M4.9 M
Pretty Stable
Other Current Assets418.4 K651.5 K737 K
Slightly volatile
Other Stockholder Equity15.9 M27.7 M6.6 M
Slightly volatile
Non Current Liabilities Other11 K11.5 K14 K
Slightly volatile
Common StockK4.2 K549.6 K
Pretty Stable
Short and Long Term Debt Total398.9 K448.7 K489.8 K
Slightly volatile
Net Receivables309 K332.1 K280.5 K
Slightly volatile
Deferred Long Term Liabilities220.9 K248.6 K271.3 K
Slightly volatile
Short Term Debt398.9 K448.7 K489.8 K
Slightly volatile
Non Currrent Assets Other1.2 M1.4 M1.5 M
Slightly volatile

Estrella Immunopharma Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative1.2 M1.6 M663.1 K
Slightly volatile
Other Operating Expenses10.7 M10.2 M2.9 M
Slightly volatile
Research Development4.1 M7.4 M2.1 M
Slightly volatile
Total Operating Expenses10.7 M10.2 M2.8 M
Slightly volatile
Total Other Income Expense Net789.8 K752.2 K207.1 K
Slightly volatile

Estrella Immunopharma Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation1.4 M1.4 M372.2 K
Slightly volatile
Other Cashflows From Financing Activities11.6 M11 M3.2 M
Slightly volatile
Change To Operating Activities1.2 M1.1 M389.2 K
Slightly volatile
Change To Netincome494.6 K471 K177.4 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Average Payables18.8 K21.1 K23 K
Slightly volatile
Cash Per Share0.02730.02870.5055
Slightly volatile
Income Quality0.940.780.9848
Pretty Stable
Current Ratio0.470.495.2113
Very volatile
Debt To Equity0.05640.06350.0693
Slightly volatile
Average Receivables115.5 K129.9 K141.8 K
Slightly volatile
Interest Debt Per Share0.06920.07790.085
Slightly volatile
Debt To Assets0.03990.04490.049
Slightly volatile
Ebt Per Ebit0.460.520.5723
Slightly volatile
Total Debt To Capitalization0.05270.05930.0647
Slightly volatile
Debt Equity Ratio0.05640.06350.0693
Slightly volatile
Quick Ratio0.470.495.2113
Very volatile
Net Income Per E B T1.131.151.0218
Slightly volatile
Cash Ratio0.260.284.4564
Very volatile
Free Cash Flow Operating Cash Flow Ratio1.11.151.0147
Slightly volatile
Debt Ratio0.03990.04490.049
Slightly volatile

Estrella Immunopharma Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap53.9 M68.2 M43.8 M
Slightly volatile
Enterprise Value51.9 M68.7 M40.5 M
Slightly volatile

Estrella Fundamental Market Drivers

About Estrella Immunopharma Financial Statements

Estrella Immunopharma stakeholders use historical fundamental indicators, such as Estrella Immunopharma's revenue or net income, to determine how well the company is positioned to perform in the future. Although Estrella Immunopharma investors may analyze each financial statement separately, they are all interrelated. For example, changes in Estrella Immunopharma's assets and liabilities are reflected in the revenues and expenses on Estrella Immunopharma's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Estrella Immunopharma. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Estrella Immunopharma is a strong investment it is important to analyze Estrella Immunopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Estrella Immunopharma's future performance. For an informed investment choice regarding Estrella Stock, refer to the following important reports:
Check out the analysis of Estrella Immunopharma Correlation against competitors.
For information on how to trade Estrella Stock refer to our How to Trade Estrella Stock guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Estrella Immunopharma. If investors know Estrella will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Estrella Immunopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.24)
Return On Assets
(1.01)
Return On Equity
(2.69)
The market value of Estrella Immunopharma is measured differently than its book value, which is the value of Estrella that is recorded on the company's balance sheet. Investors also form their own opinion of Estrella Immunopharma's value that differs from its market value or its book value, called intrinsic value, which is Estrella Immunopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Estrella Immunopharma's market value can be influenced by many factors that don't directly affect Estrella Immunopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Estrella Immunopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Estrella Immunopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Estrella Immunopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.